Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Komatsuda

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Trends in Cancer|May 7, 2025
Mixing it up: boosting responses with immunotherapy combinationsHiroki Komatsuda, Edward S Sim, Ravindra Uppaluri
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 4, 2020
Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell CarcinomaTakumi Kumai, Hiroki Komatsuda, Yoshinori Minami, et al.
Vaccines|January 22, 2022
Antitumor Peptide-Based Vaccine in the LimelightTakumi Kumai, Hidekiyo Yamaki, Michihisa Kono, et al.
Clinical Case Reports|December 28, 2020
Response to PD-1 blockade in a patient with mucosal melanoma of the middle ear: Case reportHiroki Komatsuda, Takumi Kumai, Seigo Ueda, et al.
Brazilian Journal of Otorhinolaryngology|December 12, 2024
Comparative outcomes of video-assisted thyroidectomy and traditional open surgery: a 5-year analysis of a single center experienceKenzo Ohara, Takumi Kumai, Kan Kishibe, et al.
Cancers|March 28, 2024
Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland CancersRyosuke Sato, Hidekiyo Yamaki, Hiroki Komatsuda, et al.
Vaccines|January 22, 2024
Harnessing Immunity to Treat Advanced Thyroid CancerHiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
International Journal of Cancer|December 10, 2022
Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8<sup>+</sup> T-cell functions via modulating glucose metabolism of CD11b<sup>+</sup> Ly6G<sup>+</sup> cellsAkemi Kosaka, Yuki Yajima, Shunsuke Yasuda, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|April 25, 2024
Common Characteristics of Sinonasal Inflammation Associated with IgG4-Related Disease and Other Chronic Inflammatory Diseases: A Retrospective Observational StudyRyosuke Sato, Takumi Kumai, Ryota Yuasa, et al.
Clinical and Experimental Nephrology|June 18, 2024
A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational studyRyosuke Sato, Risa Wakisaka, Hiroki Komatsuda, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Trends in Cancer|May 7, 2025
Mixing it up: boosting responses with immunotherapy combinationsHiroki Komatsuda, Edward S Sim, Ravindra Uppaluri
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 4, 2020
Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell CarcinomaTakumi Kumai, Hiroki Komatsuda, Yoshinori Minami, et al.
Vaccines|January 22, 2022
Antitumor Peptide-Based Vaccine in the LimelightTakumi Kumai, Hidekiyo Yamaki, Michihisa Kono, et al.
Clinical Case Reports|December 28, 2020
Response to PD-1 blockade in a patient with mucosal melanoma of the middle ear: Case reportHiroki Komatsuda, Takumi Kumai, Seigo Ueda, et al.
Brazilian Journal of Otorhinolaryngology|December 12, 2024
Comparative outcomes of video-assisted thyroidectomy and traditional open surgery: a 5-year analysis of a single center experienceKenzo Ohara, Takumi Kumai, Kan Kishibe, et al.
Cancers|March 28, 2024
Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland CancersRyosuke Sato, Hidekiyo Yamaki, Hiroki Komatsuda, et al.
Vaccines|January 22, 2024
Harnessing Immunity to Treat Advanced Thyroid CancerHiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
International Journal of Cancer|December 10, 2022
Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8<sup>+</sup> T-cell functions via modulating glucose metabolism of CD11b<sup>+</sup> Ly6G<sup>+</sup> cellsAkemi Kosaka, Yuki Yajima, Shunsuke Yasuda, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|April 25, 2024
Common Characteristics of Sinonasal Inflammation Associated with IgG4-Related Disease and Other Chronic Inflammatory Diseases: A Retrospective Observational StudyRyosuke Sato, Takumi Kumai, Ryota Yuasa, et al.
Clinical and Experimental Nephrology|June 18, 2024
A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational studyRyosuke Sato, Risa Wakisaka, Hiroki Komatsuda, et al.
Pageof 4